Raising eyebrows with botulinum toxin.
BACKGROUND
Brow elevation rejuvenates the facial appearance.


OBJECTIVE
To determine if a significant degree of brow elevation could be achieved through selective botulinum toxin treatment of brow depressors.


METHODS
Seven women aged 31-42 (mean 37) years old were treated. The distance from lowest eyebrow cilium of the eyebrow to the midpupillary point was measured before and 1 month posttreatment. Botulinum toxin was injected into the glabellar area (7-10U) and the supralateral eyebrow (0-2.5U each side), to a total dose of 10-14 U.


RESULTS
Five individuals (71%) showed brow elevation of 1-3 mm with a mean elevation of 1 mm. Two individuals showed no change. Concurrent weakening of the frown response was noted in all patients.


CONCLUSIONS
Botulinum toxin treatment of brow depressors produces a small degree of brow elevation in the majority of patients.
Huilgol
S C
SC
Department of Medicine, Vancouver Hospital and Health Sciences Center, Canada.
Carruthers
A
A
Carruthers
J D
JD
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005138:Eyebrows / Q000601:surgery*; D005260:Female; D006801:Humans; D015361:Rhytidoplasty / Q000379:methods*; D016896:Treatment Outcome
D019274:Botulinum Toxins, Type A